Dexibuprofen
Alternative Names: Daxfen; DexOptifen; Movone; S-(+)-Ibuprofen; Seractil; UltraprofenLatest Information Update: 20 Apr 2015
At a glance
- Originator Gebro Pharma GmbH
 - Class Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
 - Mechanism of Action Cyclooxygenase inhibitors
 
- 
          
            
              Orphan Drug Status
              No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
 - New Molecular Entity No
 
Highest Development Phases
- Marketed Back pain; Dysmenorrhoea; Headache; Inflammation; Musculoskeletal pain; Osteoarthritis; Pain; Postoperative pain; Rheumatic disorders
 
Most Recent Events
- 05 Apr 2008 Pharmacokinetics data from a Phase-I trial in healthy volunteers presented at the 109th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT-2008)
 - 13 Jul 2007 Madaus has been acquired by Rottapharm
 - 21 Feb 2006 Phase-III clinical trials in Postoperative pain in Austria (PO)